Skip to main content
Fig. 1 | BMC Ophthalmology

Fig. 1

From: Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation

Fig. 1

Intravitreal aflibercept treatment for RAP. Case 3: A 59-year-old female with a stage IIb RAP lesion. a-f Pre-treatment exams. g-l Post-treatment exams performed one month after 3 monthly IVAs. a Red-free fundus photograph showing a circumscribed area of PED with a focal area of retinal hemorrhage at the center. b Early phase ICGA demonstrating a neovascularised lesion in a macula with retino-retinal vessel anastomosis. c Late-phase FA showing dye leaking and pooling in the macula. d Late-phase ICGA revealing a “hot spot” corresponding to a neovascularised macular lesion. e, k The orientation of SD-OCT. f SD-OCT image taken before treatment showing a PED, subretinal fluid accumulation, and an overlying intraretinal lesion corresponding to the “hot spot” in late-phase ICGA. g Resolution of the circumscribed PED and the retinal hemorrhage. h The neovascularised lesion in the macula regressed. i,j Decreased dye leakage was observed in the macula, and the “hot spot” was no longer present. l Resolution of the PED and subretinal fluid. Some RPE bumps were still present

Back to article page